Ito, Yu
Kondo, Jumpei
Masuda, Masamune
Matsuzaki, Shinya
Onuma, Kunishige
Kanda, Mizuki
Watanabe, Yuko
Sakaguchi, Hitomi
Yoshino, Kiyoshi
Ueda, Yutaka
Kamiura, Shoji
Kimura, Tadashi
Inoue, Masahiro http://orcid.org/0000-0001-7315-026X
Funding for this research was provided by:
Japan Agency for Medical Research and Development (19cm0106203h0004)
Takeda Science Foundation
Article History
Received: 9 September 2022
Accepted: 11 November 2022
First Online: 7 December 2022
Declarations
:
: M.I. belong and J.K. belonged to the Department of Clinical Bio-resource Research and Development at Kyoto University, which is sponsored by KBBM, Inc. M.I. is an inventor of the patents related to CTOS method.
: This study was approved by the institutional ethics committees of the Osaka International Cancer Institute (1111112098, 1605137104), Osaka University (10182), and Kyoto University (R1575). Animal studies were approved by the Institutional Animal Study Committee of Osaka International Cancer Institute and Kyoto University and performed in compliance with the guidelines.
: Surgical specimens and ascites samples from patients with ovarian cancer were obtained from Osaka University and Osaka International Cancer Institute with the approved patients’ informed consent and permission.